Thomas Fleming

16.9k total citations · 1 hit paper
110 papers, 11.9k citations indexed

About

Thomas Fleming is a scholar working on Clinical Biochemistry, Physiology and Molecular Biology. According to data from OpenAlex, Thomas Fleming has authored 110 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Clinical Biochemistry, 37 papers in Physiology and 27 papers in Molecular Biology. Recurrent topics in Thomas Fleming's work include Advanced Glycation End Products research (59 papers), Biochemical effects in animals (14 papers) and Pain Mechanisms and Treatments (13 papers). Thomas Fleming is often cited by papers focused on Advanced Glycation End Products research (59 papers), Biochemical effects in animals (14 papers) and Pain Mechanisms and Treatments (13 papers). Thomas Fleming collaborates with scholars based in Germany, United States and United Kingdom. Thomas Fleming's co-authors include Virginia Paton, Brian Leyland‐Jones, Mark D. Pegram, W. Eiermann, Alex Bajamonde, Janet Wolter, Steven Shak, José Baselga, Larry Norton and Dennis J. Slamon and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Thomas Fleming

108 papers receiving 11.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

2001 8.4k citations Thomas Fleming et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Fleming Germany	34	6.5k	3.1k	3.0k	2.1k	1.7k	110	11.9k
Tetsuya Taguchi Japan	50	3.1k 0.5×	3.8k 1.2×	492 0.2×	2.2k 1.0×	880 0.5×	290	9.6k
Nicholas Mitsiades United States	66	4.5k 0.7×	10.1k 3.2×	823 0.3×	2.4k 1.1×	1.1k 0.7×	172	15.3k
Reinier O. Schlingemann Netherlands	60	928 0.1×	4.3k 1.4×	5.4k 1.8×	843 0.4×	426 0.3×	187	12.9k
Hiroki Kuniyasu Japan	54	3.1k 0.5×	5.4k 1.7×	252 0.1×	2.2k 1.0×	1.6k 0.9×	277	10.3k
Javid J. Moslehi United States	68	6.6k 1.0×	3.7k 1.2×	1.5k 0.5×	1.3k 0.6×	2.2k 1.3×	211	16.0k
Thomas Force United States	67	3.2k 0.5×	8.9k 2.8×	894 0.3×	1.1k 0.5×	1.4k 0.9×	158	16.8k
Gerald Höefler Austria	50	2.1k 0.3×	4.2k 1.3×	199 0.1×	2.3k 1.1×	1.1k 0.7×	192	9.3k
Anthony P. Adamis United States	67	796 0.1×	8.5k 2.7×	9.0k 3.0×	1.5k 0.7×	457 0.3×	114	21.2k
Hans‐Peter Hammes Germany	44	582 0.1×	4.6k 1.5×	1.7k 0.6×	855 0.4×	473 0.3×	179	11.7k
Mark Kockx Belgium	54	1.4k 0.2×	3.4k 1.1×	465 0.2×	1.4k 0.7×	997 0.6×	176	9.2k

Countries citing papers authored by Thomas Fleming

Since Specialization

Citations

This map shows the geographic impact of Thomas Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Fleming more than expected).

Fields of papers citing papers by Thomas Fleming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Fleming. The network helps show where Thomas Fleming may publish in the future.

Co-authorship network of co-authors of Thomas Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Fleming. A scholar is included among the top collaborators of Thomas Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Fleming. Thomas Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Ying, Andrea Schlotterer, Nadine Dietrich, et al.. (2024). Sex differences in the development of experimental diabetic retinopathy. Scientific Reports. 14(1). 22812–22812. 3 indexed citations

Othman, Alaa, Kimberly Begemann, Sonja Binder, et al.. (2024). The reactive pyruvate metabolite dimethylglyoxal mediates neurological consequences of diabetes. Nature Communications. 15(1). 5745–5745. 5 indexed citations

Kolibabka, M, Johann Gassenhuber, Nadine Dietrich, et al.. (2023). The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy. Acta Diabetologica. 60(11). 1551–1565. 10 indexed citations

Gancheva, Sofiya, S. Kahl, Dominik Pesta, et al.. (2022). Impaired Hepatic Mitochondrial Capacity in Nonalcoholic Steatohepatitis Associated With Type 2 Diabetes. Diabetes Care. 45(4). 928–937. 33 indexed citations

Morgenstern, Jakob, Jan B. Groener, Johann M. E. Jende, et al.. (2021). Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy. Diabetologia. 64(12). 2843–2855. 42 indexed citations

Pischetsrieder, Monika, et al.. (2020). Reactive dicarbonyl compounds cause Calcitonin Gene-Related Peptide release and synergize with inflammatory conditions in mouse skin and peritoneum. Journal of Biological Chemistry. 295(19). 6330–6343. 4 indexed citations

Schwarz, Dániel, Åsa Hidmark, Volker Sturm, et al.. (2020). Characterization of experimental diabetic neuropathy using multicontrast magnetic resonance neurography at ultra high field strength. Scientific Reports. 10(1). 7593–7593. 12 indexed citations

Morgenstern, Jakob, Thomas Fleming, Gernot Poschet, et al.. (2019). The combination of loss of glyoxalase1 and obesity results in hyperglycemia. JCI Insight. 4(12). 47 indexed citations

Dewenter, Matthias, Thomas Fleming, Lorenz Lehmann, et al.. (2019). O-GlcNAcylation of Histone Deacetylase 4 Protects the Diabetic Heart From Failure. Circulation. 140(7). 580–594. 93 indexed citations

10.

Schumacher, Dagmar, Jakob Morgenstern, Nadine Volk, et al.. (2018). Compensatory mechanisms for methylglyoxal detoxification in experimental & clinical diabetes. Molecular Metabolism. 18. 143–152. 55 indexed citations

11.

Sulaj, Alba, Stefan Kopf, Elisabeth Gröne, et al.. (2017). ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy. Journal of Diabetes and its Complications. 31(6). 1058–1065. 14 indexed citations

12.

Hofer, Stefan, Florian Uhle, Thomas Fleming, et al.. (2016). RAGE-mediated inflammation in patients with septic shock. Journal of Surgical Research. 202(2). 315–327. 17 indexed citations

13.

Dietrich, Nadine, M Kolibabka, Ulrike Kaiser, et al.. (2016). The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy. PLoS ONE. 11(12). e0167853–e0167853. 57 indexed citations

14.

Uhle, Florian, Christoph Lichtenstern, Thorsten Brenner, et al.. (2015). Role of the RAGE Axis during the Immune Response after Severe Trauma: A Prospective Pilot Study. Mediators of Inflammation. 2015(1). 691491–691491. 7 indexed citations

15.

Brenner, Thorsten, Thomas Fleming, Florian Uhle, et al.. (2014). Methylglyoxal as a new biomarker in patients with septic shock: an observational clinical study. Critical Care. 18(6). 683–683. 33 indexed citations

16.

Mendler, Michael, Andreas Schlotterer, Youssef Ibrahim, et al.. (2014). daf-16/FOXO and glod-4/glyoxalase-1 are required for the life-prolonging effect of human insulin under high glucose conditions in Caenorhabditis elegans. Diabetologia. 58(2). 393–401. 28 indexed citations

17.

Brenner, Thorsten, Thomas Fleming, Peter Schemmer, et al.. (2013). Reactive Metabolites and AGE-RAGE-Mediated Inflammation in Patients following Liver Transplantation. Mediators of Inflammation. 2013. 1–10. 16 indexed citations

18.

Fleming, Thomas, et al.. (2013). Methylglyoxal concentrations differ in standard and washed neonatal packed red blood cells. Pediatric Research. 75(3). 409–414. 5 indexed citations

19.

Eberhardt, Mirjam, Miloš R. Filipović, Andreas Leffler, et al.. (2012). Methylglyoxal Activates Nociceptors through Transient Receptor Potential Channel A1 (TRPA1). Journal of Biological Chemistry. 287(34). 28291–28306. 160 indexed citations

20.

Fleming, Thomas, Joanne Cuny, Zdenka Djuric, et al.. (2012). Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates?. Diabetologia. 55(4). 1151–1155. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact